Have a personal or library account? Click to login
Clinical Features and Disease Course of Cancer Patients Infected with Sars-Cov-2 During Anticancer Treatments Cover

Clinical Features and Disease Course of Cancer Patients Infected with Sars-Cov-2 During Anticancer Treatments

Open Access
|Jan 2024

References

  1. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513.
  2. World Health Organization. WHO Director General’s opening remarks at the media briefing on COVID-19. 2020. Available at: www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19. Accessed Jun 20, 2020.
  3. El-Shakankery KH, Kefas J, Crusz SM. Caring for our cancer patients in the wake of COVID-19. Br J Cancer. 2020;123(1):3-4.
  4. Lewis MA. Between Scylla and Charybdis - Oncologic Decision Making in the Time of Covid-19. N Engl J Med. 2020;382(24):2285-2287.
  5. European Society for Medical Oncology. Cancer patient management during the COVID-19 pandemic. Available at: www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic. Accessed August 2, 2020.
  6. National Institutes of Helth. COVID-19 Treatment Guidelines. Management of Persons with COVID-19. Available at: www.covid19treatmentguidelines.nih.gov/overview/management-of-covid-19. Accessed August 2, 2020.
  7. Von Lilienfeld-Toal M, Vehreschild JJ, Cornely O, et al. Frequently asked questions regarding SARS-CoV-2 in cancer patients-recommendations for clinicians caring for patients with malignant diseases. Leukemia. 2020;34(6):1487-1494.
  8. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention [published online ahead of print, 2020 Feb 24]. JAMA. 2020;10.1001/jama.2020.2648.
  9. Zhang L, Zhu F, Xie L, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020;31(7):894-901.
  10. Lee LYW, Cazier JB, Starkey T, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020;395(10241):1919-1926.
  11. World Health Organization. Clinical management of COVID-19. Interim guidance, 27 May 2020. Available at: www.who.int/publications/i/item/clinical-management-of-covid-19 . Accessed August 30, 2020.
  12. European Centre for Disease Prevention and Control. Guidance for discharge and ending isolation in the context of widespread community transmission of COVID-19 - first update. Available at: www.ecdc.europa.eu/sites/default/files/documents/covid-19-guidance-discharge-and-ending-isolation-first%20update.pdf. Accessed August 28, 2020.
  13. Wang F, Nie J, Wang H, et al. Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia. J Infect Dis. 2020;221(11):1762-1769.
  14. Czawlytko C, Hossain R, White CS. COVID-19 Diagnostic Imaging Recommendations. Appl Radiol. 2020; 49(3):10-15
  15. World Health Organization. Use of chest imaging in COVID-19. A rapid advice guide, 11. June 2020. Available at: www.who.int/publications/i/item/use-of-chest-imaging-in-covid-19. Accessed August 28, 2020.
  16. Cozzi D, Albanesi M, Cavigli E, et al. Chest X-ray in new Coronavirus Disease 2019 (COVID-19) infection: findings and correlation with clinical outcome. Radiol Med. 2020;125(8):730-737.
  17. Yang K, Sheng Y, Huang C, et al. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020;21(7):904-913.
  18. Esposito S, Noviello S, Pagliano P. Update on treatment of COVID-19: ongoing studies between promising and disappointing results. Infez Med. 2020;28(2):198-211.
  19. Lee LYW, Cazier JB, Starkey T, et al. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study [published online ahead of print, 2020 Aug 24]. Lancet Oncol. 2020;S1470-2045(20)30442-3.
  20. Vijayvargiya P, Esquer Garrigos Z, Castillo Almeida NE, Gurram PR, Stevens RW, Razonable RR. Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof). Mayo Clin Proc. 2020;95(7):1454-1466.
  21. Xu W, Piper-Vallillo AJ, Bindal P, et al. Time to SARS-CoV-2 Clearance Among Patients with Cancer and COVID-19. Preprint. medRxiv. 2020;2020.07.23.2016 1000.
DOI: https://doi.org/10.2478/sjecr-2020-0054 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Language: English
Page range: 277 - 287
Submitted on: Oct 6, 2020
|
Accepted on: Nov 30, 2020
|
Published on: Jan 2, 2024
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2024 Aleksandra Babić, Jelena Milin-Lazović, Sanja Milenković, Jelena Dobrić, Zlata Hufnagel, Nenad Miladinović, Sofija Milanović, Marina Stojanović, Sara Filipović, Aleksandar Gavrić, Nikola Borlja, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.